In this study, we investigated the clinical utility of fMET and neutrophil activation markers in RA‐ILD patients and examined the role of fMET–FPR1 signaling in neutrophil activation, aiming to provide new mechanistic and translational insights. Here, FPR1 is linked to interstitial lung disease.